<DOC>
	<DOCNO>NCT00956371</DOCNO>
	<brief_summary>The primary objective study evaluate safety tolerability ONO-7746 healthy adult subject . The secondary objective characterize pharmacokinetic pharmacodynamic profile ONO-7746 .</brief_summary>
	<brief_title>ONO-7746 Study Healthy Adult Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy nonsmoking male female subject ( 1855 year inclusive ) Body mass index ( BMI ) 1935 kg/mÂ² ( inclusive ) For female : postmenopausal , nonlactating nonpregnant History presence clinically significant disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>ONO-7746</keyword>
	<keyword>Healthy adult subject</keyword>
</DOC>